Clinical Trials Logo

Artificial Intelligence clinical trials

View clinical trials related to Artificial Intelligence.

Filter by:

NCT ID: NCT05894850 Not yet recruiting - Clinical trials for Artificial Intelligence

Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of colorectal postpolypectomy patients. The enrolled patients were divided into group A with intelligent surveillance system reminding though telephone and message, group B with intelligent surveillance system reminding though message, group C with manual reminder, and group D with natural state. The surveillance among the four groups were compared.

NCT ID: NCT05851885 Not yet recruiting - Clinical trials for Artificial Intelligence

Evaluation of the Clinical Effectiveness of Upper Gastrointestinal Endoscopy Reporting System

Start date: May 20, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to assess the effectiveness of an AI-based reporting system for upper gastrointestinal endoscopy. The primary question that this study aims to address is whether the reporting system can enhance the completeness and accuracy of endoscopic reports when assisted by AI, as drafted by endoscopists. Patients will be randomly assigned to either the experimental group or the control group. In the experimental group, physicians will draft EGD reports with the assistance of the AI-based reporting system, while in the control group, physicians will use the conventional reporting system to draft EGD reports. At the same time, the AI-based reporting system will automatically generate a report of the EGD examination.

NCT ID: NCT05847894 Not yet recruiting - Clinical trials for Artificial Intelligence

Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology

Start date: July 2023
Phase:
Study type: Observational [Patient Registry]

This study intends to collect ophthalmologic examination results, pulmonary examination results and related indexes from patients with pulmonary disease and control populations, and combine big data analysis and artificial intelligence technology to explore whether new methods can be provided for early screening strategies for pulmonary disease with the aid of ophthalmologic examination, and thus assist in identifying the types of pulmonary disease and determining disease prognosis.

NCT ID: NCT05829590 Not yet recruiting - Colonoscopy Clinical Trials

AI-assisted Colonoscopy Report System In Improving Reporting Quality

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

In this study, the investigators proposed a prospective study about the effectiveness of speech and image recognition-based system in improving reporting quality during colonoscopy for colonoscopy report quality in endoscopists. The participants would be divided into two groups. For the collected colonoscopy videos, group A would record their observations with the assistance of the artificial intelligence system. The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions. Group B would complete the endoscopy report without special prompts. After a period of washout period, the two groups switched, that is, group A without AI assistance and group B with AI assistance to complete the colonoscopy report. Then, the completeness of the colonoscopy report, the completeness of capturing anatomical landmarks and detected lesions, the completeness of structured description, the accuracy of lesion reporting, the time for reporting and the satisfaction with the reporting system are compared with or without AI assistance.

NCT ID: NCT05784935 Not yet recruiting - Clinical trials for Artificial Intelligence

Intelligent-C Endoscopy Module for Real-time Detection of Colonic Lesions

iIDEAS/RTD
Start date: March 20, 2023
Phase:
Study type: Observational

To conduct an single blinded, non-randomized, prospective, single center trial to validate the performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy and to evaluate its feasibility in daily endoscopy. Consecutive patients referred for a screening, surveillance or diagnostic colonoscopy will be included

NCT ID: NCT05751824 Not yet recruiting - Clinical trials for Artificial Intelligence

Evaluating the Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients

Start date: February 26, 2023
Phase: N/A
Study type: Interventional

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of colorectal postpolypectomy patients. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups were compared.

NCT ID: NCT05489471 Not yet recruiting - Clinical trials for Artificial Intelligence

A Study to Assess the Impact of an Artificial Intelligence (AI) System on Chest X-ray Reporting

Start date: May 2023
Phase:
Study type: Observational

The study has an initial short retrospective component but is predominately a prospective study with two main parts. Initially during a 1 month period whilst reporters are familiarising themselves with the software two local databases will be reviewed by the AI software: - A training set of 100 chest X-rays (CXR) some of which contain nodules and is used as a training tool with previously documented radiologist performance. - A set of previously reported radiographs in patients referred by the reporter for CT, ground truth created from the prior CT report and review by two radiologists if required. This will allow comparison of stand-alone radiologist and AI performance This is followed by a 6 month period involving multiple groups of reporters and approximately 20,000 cases looking at the impact of an AI system which assesses 10 abnormalities on chest X-ray and reporting on the sensitivity for detection of lesions and its impact on reporter confidence. Specifically the investigators would look at: - Missed finding by AI, but detected by reporter - Correctly detected finding by AI - Missed finding by the reporter but detected by AI - Finding detected by AI but disputed by the reporter ■ AI's impact on - Radiological report - Further recommended imaging - Altering patient management - improvement in report confidence as perceived by reporter A subsequent 3 month period looking at the impact of AI produced worklists on report turnaround times and the patient pathway from chest X-ray to CT. the investigators would specifically look at: - number of nodules detected - number of CXRs recommended for follow up CT - time taken from CXR to CT - number of lung cancers detected after CT[1] - Time to report, measured as previously from PACS and reporting software data The population to be studied will be all patients over 16 years of age referred by their General Practitioner to Hull University Hospitals NHS Trust for a chest radiograph and any chest radiograph performed in the Hull Royal Infirmary ED radiology for patients over 16 years of age during the 6 month study period. The ED department images patients from the emergency department and in-patients within the hospital. All radiographs will be reviewed initially without review of the AI information and then using the additional images. Reporters will mark the effect of the AI on their decision. All disagreements between the reporter and the AI will be reviewed by senior reporters and a consensus decision made.

NCT ID: NCT05452993 Not yet recruiting - Diabetes Mellitus Clinical Trials

Screening for Diabetic Retinopathy in Pharmacies With Artificial Intelligence Enhanced Retinophotography

DIABeyeIA
Start date: September 2022
Phase: N/A
Study type: Interventional

Diabetic retinopathy is frequent, potentially severe with visual threat, health costly and represents a major public health problem. However, screening compliance for retinopathy remains too low in France, approximately 40% patients with diabetes laking diabetic retinopathy screening for at least 2 years. DIABeyeIA is a prospective pilot study evaluating the effectiveness and acceptability of diabetic retinopathy screening in 11 pharmacies in Normandy (north of France) using a non-mydriatic portable retinophotograph enhanced by artificial intelligence software. The main goal of this work is to evaluate a potential increase rate of diabetic retinopathy screening, compared to the actual rate (64% in France). Secondary goals are faisability, satisfaction and economical considerations for implementation of such a new screening program.

NCT ID: NCT05369572 Not yet recruiting - Clinical trials for Artificial Intelligence

Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence

Start date: June 30, 2022
Phase:
Study type: Observational

By introducing artificial intelligence into Chinese medicine tongue diagnosis, we collated and collected tongue images, anxiety and depression scales and gastroscopy reports, mined and analysed the correlation between tongue images and bile reflux and anxiety and depression and constructed a prediction model to analyse the possibility of predicting bile reflux and anxiety and depression in patients based on tongue images.

NCT ID: NCT05368636 Not yet recruiting - Gastric Cancer Clinical Trials

Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence

Start date: June 30, 2022
Phase:
Study type: Observational

This study combines artificial intelligence with tongue images, by collating and collecting tongue images and diagnostic and pathological results of gastroscopic diseases, mining and analysing the correlation between tongue images and OLGA, OLGIM stages, Correa sequences and constructing prediction models, to deeply investigate the relationship between tongue images and precancerous diseases, precancerous lesions and gastric cancer.